Clinical and pathological disappearance of peritoneal dissemination in a patient with advanced gastric cancer receiving chemotherapy with S-1 and low-dose cisplatin

被引:4
|
作者
Akatsu Y. [1 ]
Saikawa Y. [1 ]
Kubota T. [1 ]
Yoshida M. [1 ]
Furukawa T. [1 ]
Otani Y. [1 ]
Kumai K. [2 ]
Kitajima M. [1 ]
机构
[1] Department of Surgery, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582
[2] Ctr. for Diagn./Therapeut. Endoscopy, Keio University School of Medicine, Tokyo
关键词
Cisplatin; Gastric cancer; Peritoneal dissemination; S-1;
D O I
10.1007/s10120-004-0281-8
中图分类号
学科分类号
摘要
A 54-year-old woman with severe abdominal distention suffered from massive ascites. Cytological examination revealed adenocareinoma cells, leading to a diagnosis of peritonitis carcinomatosa. Gastrointestinal fiberseopy (GIF) resulted in a histological diagnosis of type 4 advanced gastric cancer with signet-ring cell carcinoma. The clinical diagnosis was confirmed to be cT3(SE)cN1cM0cH0cP1, cStage IV gastric cancer, type 4, according to the Japanese classification of gastric carcinoma. The patient was treated with S-1 and low-dose cisplatin (CDDP) in order to alleviate the critical state of the disease. After the third cycle of the regimen, the clinical response of P1 was classified as a partial response (PR) according to the World Health Organization (WHO) criteria. The patient's appetite loss and abdominal discomfort were markedly alleviated. The patient experienced grade 2 leukocytopenia throughout the regimen. Surgery was performed. Ascites and peritoneal disseminated lesions were not observed, and cytological examination of the peritoneal washes was negative. Total gastrectomy with D1 lymph node dissection was performed, and the surgical diagnosis was sT3(SE)sN0sM0sH0sP0; sStage II Microscopically, viable cancer cells were found to be scattered throughout the subserosal-serosal layers in the resected stomach. All of the samples from lesions that were potentially cancers involving peritoneal dissemination were diagnosed as fibrous scar tissues without any viable cancer cells. The patient is alive without recurrence at 10 months after surgery and 14 months after the initial chemotherapy. Thus, systemic chemotherapy with S-1/low-dose CDDP achieved desirable control of peritoneal disseminated cells, as assessed microscopically, suggesting that the regimen may be an effective strategy for the treatment of advanced gastric cancer with peritonitis carcinomatosa.
引用
收藏
页码:128 / 133
页数:5
相关论文
共 50 条
  • [21] S-1 and the treatment of gastric cancer with peritoneal dissemination
    Izuishi, Kunihiko
    Haba, Reiji
    Kushida, Yoshio
    Kadota, Kyuichi
    Takebayashi, Ryusuke
    Sano, Takanori
    Usuki, Hisashi
    Hossain, Mohammad Akram
    Mori, Hirohito
    Masaki, Tsutomu
    Suzuki, Yasuyuki
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (05) : 985 - 990
  • [22] Feasibility and Efficacy of Combination Chemotherapy with S-1 and Fractional Cisplatin for Advanced Gastric Cancer
    Takahashi, Tsunehiro
    Saikawa, Yoshiro
    Takaishi, Hiromasa
    Takeuchi, Hiroya
    Wada, Norihito
    Oyama, Takashi
    Nakamura, Rieko
    Kitagawa, Yuko
    ANTICANCER RESEARCH, 2010, 30 (09) : 3759 - 3762
  • [23] A feasibility study of outpatient chemotherapy with S-1 + cisplatin in patients with advanced gastric cancer
    Shunsuke Okazaki
    Takako E. Nakajima
    Jun Hashimoto
    Seiichiro Yamamoto
    Daisuke Takahari
    Ken Kato
    Tetsuya Hamaguchi
    Yasuhide Yamada
    Yasuhiro Shimada
    Kenji Tamura
    Gastric Cancer, 2013, 16 : 41 - 47
  • [24] Multicenter phase II study of S-1 and docetaxel combination chemotherapy for advanced or recurrent gastric cancer patients with peritoneal dissemination
    Shigeyasu, Kunitoshi
    Kagawa, Shunsuke
    Uno, Futoshi
    Nishizaki, Masahiko
    Kishimoto, Hiroyuki
    Gochi, Akira
    Kimura, Toshikazu
    Takahata, Takaomi
    Nonaka, Yasuyuki
    Ninomiya, Motoki
    Fujiwara, Toshiyoshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 937 - 943
  • [25] Multicenter phase II study of S-1 and docetaxel combination chemotherapy for advanced or recurrent gastric cancer patients with peritoneal dissemination
    Kunitoshi Shigeyasu
    Shunsuke Kagawa
    Futoshi Uno
    Masahiko Nishizaki
    Hiroyuki Kishimoto
    Akira Gochi
    Toshikazu Kimura
    Takaomi Takahata
    Yasuyuki Nonaka
    Motoki Ninomiya
    Toshiyoshi Fujiwara
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 937 - 943
  • [26] Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer
    Tamura, Shigeyuki
    Miki, Hirofumi
    Nakata, Ken
    Takiuchi, Daisuke
    Okada, Kaoru
    Nakahira, Shin
    Okamura, Shu
    Sugimoto, Keishi
    Tomita, Naohiro
    Takatsuka, Yuichi
    GASTRIC CANCER, 2007, 10 (04) : 251 - 255
  • [27] Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer
    Shigeyuki Tamura
    Hirofumi Miki
    Ken Nakata
    Daisuke Takiuchi
    Kaoru Okada
    Shin Nakahira
    Shu Okamura
    Keishi Sugimoto
    Naohiro Tomita
    Yuichi Takatsuka
    Gastric Cancer, 2007, 10 : 251 - 255
  • [28] Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer
    Hideo Baba
    Manabu Yamamoto
    Kazuya Endo
    Yasuharu Ikeda
    Yasushi Toh
    Shunji Kohnoe
    Takeshi Okamura
    Gastric Cancer, 2003, 6 (Suppl 1) : 45 - 49
  • [29] Clinical Experience with Chemoradiotherapy Comprising S-1 Plus Low-dose Cisplatin in a Patient with Stage IV Anal Cancer
    Nitori, Nobuhiro
    Kato, Yutaro
    Kato, Ayu
    Deguchi, Tomoaki
    Okada, Akihiro
    Kojima, Masayuki
    Kuroda, Junko
    Kadomura, Tomohisa
    Kubota, Keisuke
    Origuchi, Nobuto
    Fujisaki, Masato
    Kitajima, Masaki
    ANTICANCER RESEARCH, 2011, 31 (11) : 3983 - 3989
  • [30] Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer
    Sasaki, Kinro
    Onodera, Shinichi
    Otsuka, Kichiro
    Satomura, Hitoshi
    Kurayama, Eigo
    Kubo, Tsukasa
    Takahashi, Masakazu
    Ito, Jun
    Nakajima, Masanobu
    Yamaguchi, Satoru
    Miyachi, Kazuhito
    Kato, Hiroyuki
    MEDICAL ONCOLOGY, 2017, 34 (08)